Evidence map›Paper›PMID 33194357›Full record

ArticlePeerJ2020

Usefulness of the cytokines expression of Th1/Th2/Th17 and urinary CD80 excretion in adult-onset minimal change disease.

Ping Chen, Yan Chen, Maoqing Jiang, Yijun Mo, Huanhuan Ying, Xun Tang, Jun Zhang

Open access · goldAbstract read
In one paragraph

Article in PeerJ, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Ping ChenDepartment of Nephrology, Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong, China.
Yan ChenDepartment of Physical Examination, Ningbo First hospital, Ningbo, Zhejiang, China.
Maoqing JiangDepartment of Nuclear Medicine, Ningbo First Hospital, Ningbo, Zhejiang, China.
Yijun MoDepartment of Laboratory Medicine, Ningbo First Hospital, Ningbo, Zhejiang, China.
Huanhuan YingDepartment of Laboratory Medicine, Ningbo First Hospital, Ningbo, Zhejiang, China.
Xun TangDepartment of Nephrology, Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong, China.
Jun ZhangDepartment of Nephrology, Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong, China.
Ningbo First Hospital · CNSouthern Medical University · CNZhujiang Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMinimal change disease (MCD) is a common form of nephrotic syndrome in adults. However, the molecular mechanism underlying the pathogenesis of MCD remains incompletely understood. In this study, we aimed to investigate the role of the cytokines expression of Th1/Th2/Th17 and urinary CD80 excretion in adult-onset MCD patients.

methodsThe lymphocyte subsets, 34 cytokine levels of Th1/Th2/Th17, serum and urine concentrations of CD80, and expression of CD80 in glomeruli were analyzed in 28 cases (15 males and 13 females; average age: 34.1 years, age range: 18-56 years), including 10 patients with MCD in relapse, nine patients with MCD in remission and nine healthy controls.

resultsThere was no significant difference of CD3

conclusionsThe cytokines GM-CSF and TRANCE are increased and the urinary CD80 levels are elevated in adult-onset MCD patients in relapse, indicating a disorder of Th1/Th2/Th17 balance and that the elevated excretion of CD80 may underlie the pathogenesis and development of adult-onset MCD.

Indexed as

Adult-onset minimal change diseaseCD80Th1/Th2/Th17

Identifiers

PMID33194357
PMCPMC7485503
OpenAlexW3084165523

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.